Hypertenion: Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management

No abstract is available for this paper.

• Publication year

  2007

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1345/aph.1K311PMID 17925496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National

  2009cited by this paper
• Systematic Reviews of Pharmacy Practice Research: Methodologic Issues in Searching, Evaluating, Interpreting, and Disseminating Results

  2009cited by this paper
• A Systematic Review of Interventions to Improve Diabetes Care in Socially Disadvantaged Populations A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. DOI: 10.2337/dc05-1942

  2006cited by this paper
• Role of the Pharmacist in the Management of Dyslipidemia

  2006cited by this paper
• Pharmaceutical care program for patients with uncontrolled hypertension. Report of a double-blind clinical trial with ambulatory blood pressure monitoring.

  2006cited by this paper
• Evaluation of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center.

  2006cited by this paper
• Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.

  2006cited by this paper
• Coronary Artery Disease and Hypertension: Outcomes of a Pharmacist‐Managed Blood Pressure Program

  2006cited by this paper
• Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis.

  2006cited by this paper
• Clinical Impact of a Pharmacist‐Managed Diabetes Mellitus Drug Therapy Management Service

  2006cited by this paper
• Effectiveness of a Two‐Part Educational Intervention to Improve Hypertension Control: A Cluster‐Randomized Trial

  2006cited by this paper
• Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once‐daily atorvastatin

  2006cited by this paper
• Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease.

  2006cited by this paper
• Development and clinical outcomes of pharmacist-managed diabetes care clinics.

  2006cited by this paper
• Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention

  2005cited by this paper
• Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.

  2005cited by this paper
• Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)

  2005cited by this paper
• Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes.

  2005cited by this paper
• Long‐Term Impact of a Community Pharmacist Intervention on Cholesterol Levels in Patients at High Risk for Cardiovascular Events: Extended Follow‐up of the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP‐plus)

  2005cited by this paper
• Impact of a Pharmaceutical Care Program in a Community Pharmacy on Patients with Dyslipidemia

  2005cited by this paper
• A cost‐effectiveness analysis of a community pharmacist‐initiated disease state management service for type 2 diabetes mellitus

  2005cited by this paper
• Positive benefits of a pharmacist-managed hypertension clinic in Nigeria.

  2005cited by this paper
• Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.

  2005cited by this paper
• Effectiveness of Pharmacist‐Administered Diabetes Mellitus Education and Management Services

  2005cited by this paper
• Effectiveness of Interventions by Community Pharmacists to Improve Patient Adherence to Chronic Medication: A Systematic Review

  2005cited by this paper
• Lipid Levels and Use of Lipid-Lowering Drugs for Patients in Pharmacist-Managed Lipid Clinics Versus Usual Care in 2 VA Medical Centers

  2005cited by this paper
• Achieving Cholesterol Target in a Managed Care Organization (ACTION) Trial

  2005cited by this paper
• Clinical Outcomes Associated with Pharmacist Involvement in Patients with Dyslipidemia

  2005cited by this paper
• A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.

  2005cited by this paper
• Assessing adherence to statin therapy using patient report, pill count, and an electronic monitoring device.

  2005cited by this paper
• Providing Diabetes Education and Care to Underserved Patients in a Collaborative Practice at a Utah Community Health Center

  2005cited by this paper
• Pharmacist Impact on Clinical Outcomes in a Diabetes Disease Management Program via Collaborative Practice

  2005cited by this paper
• Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial.

  2005cited by this paper
• Health‐related quality of life in hypertension: impact of a pharmacy intervention programme

  2005cited by this paper
• Implementation of a Pharmacist-Led Clinic for Hypertensive Patients in Primary Care – A Pilot Study

  2005cited by this paper
• Impact on medication use and adherence of Australian pharmacists' diabetes care services.

  2005cited by this paper
• Implementation and evaluation of Australian pharmacists' diabetes care services.

  2004cited by this paper
• The Relationship Between Literacy and Glycemic Control in a Diabetes Disease-Management Program

  2004cited by this paper
• Pharmacist-run lipid management program in rural Alabama.

  2004cited by this paper
• Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes

  2004cited by this paper
• Cost of a Pharmacist‐Directed Intervention to Increase Treatment of Hypercholesterolemia

  2004cited by this paper
• Greater Effect of Enhanced Pharmacist Care on Cholesterol Management in Patients with Diabetes Mellitus: A Planned Subgroup Analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)

  2004cited by this paper
• Development and Preliminary Testing of a Patient Decision Aid to Assist Pharmaceutical Care in the Prevention of Cardiovascular Disease

  2004cited by this paper
• Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team – a pilot study

  2004cited by this paper
• Experience-based group education in Type 2 diabetes: a randomised controlled trial.

  2004cited by this paper
• Benefits of Individualized Counseling by the Pharmacist on the Treatment Outcomes of Hyperlipidemia in Hong Kong

  2004cited by this paper
• Glycosylated Hemoglobin, Cardiovascular, and Renal Outcomes in a Pharmacist-Managed Clinic

  2004cited by this paper
• Impact of pharmacist‐conducted home visits on the outcomes of lipid‐lowering drug therapy

  2004cited by this paper
• Failure of Computerized Treatment Suggestions to Improve Health Outcomes of Outpatients with Uncomplicated Hypertension: Results of a Randomized Controlled Trial

  2004cited by this paper
• The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels.

  2003cited by this paper
• The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

  2003cited by this paper
• Pharmacist Intervention Program for Control of Hypertension

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Pharmacist Led, Primary Care-Based Disease Management Improves Hemoglobin Aic in High-Risk Patients With Diabetes

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Improving hypertension care in a large group-model MCO.

  2003cited by this paper
• Improving primary care in rural Alabama with a pharmacy initiative.

  2003cited by this paper
• Pharmaceutical Care Services for Patients with Hypertension

  2003cited by this paper
• Assessment of Clinical Pharmacist Management of Lipid-Lowering Therapy in a Primary Care Setting

  2003cited by this paper
• Pharmacist-Managed Lipid Clinics: Development and Implementation in the Canadian Forces

  2003cited by this paper
• A Comparison of Orlistat Use in a Veteran Population: A Pharmacist-Managed Pharmacotherapy Weight-Loss Clinic versus Standard Medical Care

  2003cited by this paper
• Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness.

  2003cited by this paper
• Physician‐Pharmacist Comanagement of Hypertension: A Randomized, Comparative Trial

  2003cited by this paper
• A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

  2002cited by this paper
• A Retrospective Cohort Analysis of the Clinical Effectiveness of a Physician‐Pharmacist Collaborative Drug Therapy Management Diabetes Clinic

  2002cited by this paper
• Optimizing Drug Therapy in Patients with Cardiovascular Disease: The Impact of Pharmacist‐Managed Pharmacotherapy Clinics in a Primary Care Setting

  2002cited by this paper
• Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic

  2002cited by this paper
• Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal.

  2002cited by this paper
• A randomised controlled trial of a pharmaceutical care programme in high‐risk diabetic patients in an outpatient clinic

  2002cited by this paper
• Development of a Pharmacist-Managed Lipid Clinic

  2002cited by this paper
• A randomized trial comparing intensive and passive education in patients with diabetes mellitus.

  2002cited by this paper
• A multifaceted intervention in support of diabetes treatment guidelines: a cont trial.

  2002cited by this paper
• The Value of Pharmacist Involvement in a Point‐of‐Care Service, Walk‐In Lipid Screening Program

  2001cited by this paper
• Development of a pharmacist‐led cholesterol screening and lipid‐lowering medication review service in coronary artery bypass graft patients

  2001cited by this paper
• Pharmacoeconomic Evaluation of a Pharmacist‐Managed Hypertension Clinic

  2001cited by this paper
• Effects of Pharmacists' Consultation on Serum Cholesterol Level Using Drug History Notebook or Drug Instruction Sheets for Outpatients with Hypercholesterolemia

  2001cited by this paper
• Can Clinical Pharmacists Affect SF-36 Scores in Veterans at High Risk for Medication-Related Problems?

  2001cited by this paper
• Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care.

  2001cited by this paper
• The pharmaceutical care of patients with hypertension: an examination of service models in primary care in the US

  2001cited by this paper
• Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic.

  2001cited by this paper
• Effect of a Clinical Pharmacist‐Managed Lipid Clinic on Achieving National Cholesterol Education Program Low‐Density Lipoprotein Goals

  2000cited by this paper
• Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

  2000cited by this paper
• Pharmaceutical care for patients with chronic conditions.

  2000cited by this paper
• An Economic Analysis of a Randomized, Controlled, Multicenter Study of Clinical Pharmacist Interventions for High‐Risk Veterans: The IMPROVE Study

  2000cited by this paper
• Pharmaceutical care services and results in project ImPACT: hyperlipidemia.

  2000cited by this paper
• Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting.

  2000cited by this paper
• Clinical and Economic Impact of Ambulatory Care Clinical Pharmacists in Management of Dyslipidemia in Older Adults: The IMPROVE Study

  2000cited by this paper
• The Role of Pharmacists in the Detection, Management, and Control of Hypertension: A National Call To Action

  2000cited by this paper
• Extended adherence support by community pharmacists for patients with hypertension: a randomised controlled trial

  2000cited by this paper
• Effect of a Pharmacist-Managed Diabetes Care Program in a Free Medical Clinic

  2000cited by this paper
• Patient compliance and blood pressure control on a nuclear-powered aircraft carrier: impact of a pharmacy officer.

  2000cited by this paper
• Implementation and Evaluation of a Pharmacist-managed Diabetes Service

  2000cited by this paper
• Effect of Pharmacist Intervention and Initiation of Home Blood Pressure Monitoring in Patients with Uncontrolled Hypertension

  2000cited by this paper
• Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers.

  2000cited by this paper
• Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults.

  1999cited by this paper
• Diabetes management in a health maintenance organization. Efficacy of care management using cluster visits.

  1999cited by this paper
• Academic detailing improves identification and reporting of adverse drug events

  1999cited by this paper
• Outcomes of a community pharmacy-based diabetes monitoring program.

  1999cited by this paper
• Management of Patients with Type 2 Diabetes by Pharmacists in Primary Care Clinics

  1998cited by this paper
• Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study.

  1998cited by this paper

• Association of family pharmacist continuity with patient-reported satisfaction in patients with metastatic cancer: a nationwide cross-sectional study

  2026cites this paper
• Assessment of Knowledge, Attitudes, and Practices KAP Regarding Coronary Heart Disease Risk Factors in Ramadi City, Iraq

  2025cites this paper
• The effect of repeated hot water immersion on vascular function, blood pressure and central haemodynamics in individuals with type 2 diabetes mellitus.

  2024cites this paper
• Evaluating the implementation of a hypertension program based on mHealth and community pharmacies integration to primary care centers at a municipality level in Argentina during the COVID-19 pandemic

  2024cites this paper
• Availability and Price Variations of Commonly Used Cardiovascular Medicines at Community and Hospital Pharmacies in Gondar Town, Northwest Ethiopia

  2024cites this paper
• Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?

  2024cites this paper
• Does Collaboration between General Practitioners and Pharmacists Improve Risk Factors for Cardiovascular Disease and Diabetes? A Systematic Review and Meta-Analysis

  2023cites this paper
• Effect of Medication Therapy Management by Pharmaceutical Care on Blood Pressure and Cardiovascular Risk in Hypertension: A Systematic Review, Meta-Analysis, and Meta-Regression

  2023cites this paper
• Real-World Effectiveness in Hypertension and Hyperlipidemia Collaborative Management between Pharmacies and Primary Care in Portugal: A Multicenter Pragmatic Controlled Trial (USFarmácia®)

  2023cites this paper
• Innovative Remote Management Solutions for the Control of Hypertension

  2023cites this paper
• Community pharmacist-led interventions to improve medication adherence in patients with cardiovascular disease: a systematic review of randomised controlled trials.

  2023cites this paper
• Evidence of Improvement of Lower Limb Functioning Using Hydrotherapy on Spinal Cord Injury Patients

  2023cites this paper
• Knowledge of cardiovascular disease risk factors, practice, and barriers of community pharmacists on cardiovascular disease prevention in North West Ethiopia

  2022cites this paper
• Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially

  2022cites this paper
• Community pharmacists perception and role in the prevention and management of cardiovascular disease conditions: Evidence from Ghana.

  2022cites this paper
• Access to Telepharmacy Services May Reduce Hospital Admissions in Outpatient Populations During the COVID-19 Pandemic

  2022cites this paper
• A systematic review on the impact of pharmacist‐provided services on patients’ health outcomes in Arab countries

  2022cites this paper
• Working With the Numbers - Pharmacists and Hypertension.

  2022cites this paper
• The evolving profile of cognitive pharmaceutical services in Australia.

  2021cites this paper
• The impact of clinical pharmacy services on patients with hypertension

  2021cites this paper
• Knowledge, Attitude, and Practice of Diabetes Mellitus

  2021cites this paper
• Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial

  2021cites this paper
• Assessment of clinical inertia in people with diabetes within primary care.

  2020cites this paper
• Effect of pharmacist interventions on reducing low-density lipoprotein cholesterol (LDL-C) levels: A systematic review and meta-analysis.

  2020cites this paper
• The role of community pharmacists and their position in the delivery of diabetes care: an update for medical professionals

  2020cites this paper
• Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment

  2020cites this paper
• Characteristics of studies of pharmacist services registered in ClinicalTrials.gov.

  2020cites this paper
• Prospective study to optimize the health of patients with TIAS (transient ischemic attack) and stroke admitted to the Hamad General Hospital

  2020cites this paper
• Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment

  2020cites this paper
• More than coffee – a World Café to explore enablers of pharmacy practice research

  2020cites this paper
• Multiprofessional intervention to improve adherence to medication in stroke patients: a study protocol for a randomised controlled trial (ADMED AVC study)

  2020cites this paper
• Opportunistic screening of cardiovascular disease risk factors in community pharmacies in Nigeria: a cross-sectional study

  2020cites this paper
• Predictors of response to ambulatory pharmacist‐led diabetes care

  2020cites this paper
• Pharmacy practice research - A call to action.

  2020cites this paper
• Using network analysis to explore factors moderating the implementation of a medication review service in community pharmacy.

  2020cites this paper
• The role of the pharmacist in hypertension management: a model application in primary health care

  2020cites this paper
• Mortality in Critically Ill Elderly Individuals Receiving Mechanical Ventilation

  2019cites this paper
• Pharmaceutical care practices among registered community pharmacists in a state in southeast Nigeria: a frontier dynamics assessment

  2019cites this paper
• Integrating pharmacists into Aboriginal Community Controlled Health Services (IPAC project): Protocol for an interventional, non-randomised study to improve chronic disease outcomes.

  2019cites this paper
• The Effectiveness of Physical Activity Interventions for Low-Income and Ethnic Minority Children and Youths: A Meta-Analysis.

  2019cites this paper
• General practitioner and pharmacist collaboration: does this improve risk factors for cardiovascular disease and diabetes? A systematic review protocol

  2019cites this paper
• Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes

  2019cites this paper
• Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?

  2019cites this paper
• Patient selection and general practitioners' perception of collaboration in medication review.

  2019cites this paper
• The Role of Pharmacist in Managing Hypertension in the Community: Findings from a Community Based Study

  2019cites this paper
• Efficacy of aquatic therapy for neck pain: a systematic review

  2019cites this paper
• Optimal staffing in community health centers to improve quality of care.

  2019cites this paper
• Pilot and Feasibility of Combining a Medication Adherence Intervention and Group Diabetes Education for Patients with Type-2 Diabetes

  2019cites this paper
• Diabetes policies and pharmacy-based diabetes interventions in Portugal: a comprehensive review

  2019cites this paper
• General practitioner–pharmacist collaboration in Germany: an explanatory model

  2019cites this paper
• Implementation of an innovative surgical pharmacy service to improve patient outcomes—Twelve‐month outcomes of the Enhanced Surgical Medicines Optimization Service

  2019cites this paper
• Pharmacist-provided services and community pharmacist integration into a patient-centered medical home: A qualitative study of primary care clinic staff perceptions.

  2019cites this paper
• Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review

  2019cites this paper
• Effect of Electronic Health Record–Based Medication Support and Nurse-Led Medication Therapy Management on Hypertension and Medication Self-management: A Randomized Clinical Trial

  2018cites this paper
• A randomized controlled study to evaluate the effect of pharmacist-led educational intervention on glycemic control, self-care activities and disease knowledge among type 2 diabetes patients

  2018cites this paper
• Interventions to improve medication adherence among Chinese patients with hypertension: a systematic review and meta‐analysis of randomized controlled trails

  2018cites this paper
• Development and psychometrics of a short-form pharmaceutical care-specific measure for quality of life

  2018cites this paper
• Hypolipidemic effect and protection ability of liver-kidney functions of melanin from Lachnum YM226 in high-fat diet fed mice.

  2018cites this paper
• The Community Pharmacist’s Role in Reducing Cardiovascular Risk Factors in Lebanon: A Longitudinal Study

  2018cites this paper
• AN INTERVENTIONAL STUDY ON ADHERENCE AND BLOOD PRESSURE CONTROL IN A TERTIARY HEALTH FACILITY IN NORTH-WEST NIGERIA

  2018cites this paper
• "An Assessment of Collaboration Between Members of the Healthcare Team in Providing Medication Therapy Management (MTM)"

  2018cites this paper
• Development and evaluation of an algorithm-based tool for Medication Management in nursing homes: the AMBER study protocol

  2018cites this paper
• Defining an ‘older’ patient in the context of therapeutic decision making: perspectives of Australian pharmacists and nurses

  2018cites this paper
• The role of community pharmacists in disease prevention: A study of the delivery of clinical pharmacy services in community pharmacy in Ireland

  2018cites this paper
• Évaluation de la sévérité des problèmes liés à la pharmacothérapie chez les patients souffrant d’insuffisance rénale chronique : la perspective de la pharmacie communautaire

  2018cites this paper
• Defining an ‘older’ patient in the context of therapeutic decision making: perspectives of Australian pharmacists and nurses

  2018cites this paper
• Factors affecting medication adherence in community-managed patients with hypertension based on the principal component analysis: evidence from Xinjiang, China

  2018cites this paper
• Assessing the influence of health systems on Type 2 Diabetes Mellitus awareness, treatment, adherence, and control: A systematic review

  2018cites this paper
• 48 – Team-Based Care for Hypertension Management

  2018cites this paper
• Cost-effectiveness analysis of pharmaceutical care for hypertensive patients from the perspective of the public health system in Brazil

  2018cites this paper
• Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study

  2018cites this paper
• Physician–pharmacist collaborative practice and telehealth may transform hypertension management

  2018cites this paper
• Effective Interventions for Diabetes Patients by Community Pharmacists: A Meta-analysis of Pharmaceutical Care Components

  2018cites this paper
• Effectiveness of pharmacist’s intervention in the management of cardiovascular diseases

  2018influential citation
• The effectiveness of hydrokinesiotherapy on postural balance of hemiplegic patients after stroke: a systematic review and meta-analysis

  2018cites this paper
• Correction to: Knowledge of cardiovascular disease risk factors and practice of primary prevention of cardiovascular disease by Community Pharmacists in Nigeria: a cross-sectional study

  2018cites this paper
• Assessment of a simulated contraceptive prescribing activity for pharmacy students.

  2017cites this paper
• Effects of aquatic exercise on physical function and fitness among people with spinal cord injury

  2017cites this paper
• Implication du pharmacien d’officine dans le parcours de soins de la maladie rénale chronique

  2017cites this paper
• Cost analysis for the implementation of a medication review with follow-up service in Spain

  2017cites this paper
• The Application of Pharmaceutical Care Program on Patients with Dyslipidemia in Iraqi Community Pharmacy

  2017cites this paper
• Medication therapy disease management: Geisinger's approach to population health management.

  2017cites this paper
• Effect of a Pharmacist-Led Program on Improving Outcomes in Patients with Type 2 Diabetes Mellitus from Northern Cyprus: A Randomized Controlled Trial.

  2017cites this paper
• The complexity of implementation factors in professional pharmacy services.

  2017cites this paper
• Medication use in patients with chronic kidney disease

  2017cites this paper
• Pharmacists' Scope of Practice: Supports for Canadians with Diabetes.

  2017cites this paper
• An analysis of inter‐professional collaboration in osteoporosis screening at a primary care level using the D'Amour model

  2017cites this paper
• Patient-oriented education and medication management intervention for people with decompensated cirrhosis: study protocol for a randomized controlled trial

  2017cites this paper
• Development and validation of a pharmacoeconomic tool for decision making in the implementation of pharmaceutical care for hypertensive patients in the Brazilian public health system (SUS)

  2017cites this paper
• EFECTOS DE LA INTERVENCIÓN FARMACÉUTICA EN PACIENTES CON PRESIÓN ARTERIAL ELEVADA SIN TRATAMIENTO FARMACOLÓGICO EN FARMACIAS COMUNITARIAS DE LA PROVINCIA DE CÓRDOBA

  2017cites this paper
• Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report

  2017cites this paper
• Impact of providing psychiatry specialty pharmacist intervention on reducing drug‐related problems among children with autism spectrum disorder related to disruptive behavioural symptoms: A prospective randomized open‐label study

  2017cites this paper
• Effects of Pharmacy-Based Interventions on the Control and Management of Diabetes in Adults: A Systematic Review and Meta-Analysis.

  2017cites this paper
• U . S . Pharmacists ' Effects as Team Members on Patient Care : Systematic Review and Meta-Analyses

  2017cites this paper
• How to best manage time interaction with patients? Community pharmacist workload and service provision analysis

  2017cites this paper
• A community pharmacy-based cardiovascular risk screening service implemented in Iran

  2017cites this paper
• Quality indicators of pharmacists' services in community pharmacies in Paraná State, Brazil

  2017cites this paper
• Biological activities and biomedical potential of sea cucumber (Stichopus japonicus): a review

  2017cites this paper
• Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis

  2017cites this paper
• Modelling elderly patients’ perception of the community pharmacist image when providing professional services*

  2017cites this paper